M Ashrafizadeh, M Najafi, P Makvandi… - Journal of cellular …, 2020 - Wiley Online Library
Lung cancer is a main cause of death all over the world with a high incidence rate. Metastasis into neighboring and distant tissues as well as resistance of cancer cells to …
L Yixuan, MA Qaria, S Sivasamy, S Jianzhong… - Industrial Crops and …, 2021 - Elsevier
Curcuma longa, a perennial herb of the family genus turmeric, was used as a natural pigment in the food industry in the ancient era. The medicinal efficacy and function of …
C Tang, J Liu, C Yang, J Ma, X Chen, D Liu, Y Zhou… - Biomolecules, 2022 - mdpi.com
Researchers have made crucial advances in understanding the pathogenesis and therapeutics of non-small cell lung cancer (NSCLC), improving our understanding of lung …
B Kelly, D Thamm, RJ Rosengren - … and Comparative Oncology, 2023 - Wiley Online Library
Canine osteosarcoma is an aggressive cancer, comprising 85% of canine bone neoplasms. Current treatment practices of surgery and chemotherapy increase 1‐year survival by only …
A Bahmani, Z Najafi, G Chehardoli - Organic Preparations and …, 2022 - Taylor & Francis
Curcumin is of intensive current interest for its biological activities, including the prevention and treatment of cancer. Curcumin induces apoptosis and stops the cell cycle in different …
MA Berry, AR Bland, JC Ashton - Scientific Reports, 2023 - nature.com
Lung cancer is a major cause of cancer-related deaths. Alectinib is the first line of treatment for patients with ALK-positive lung cancer, but the survival rate beyond 2–3 years is low. Co …
Cell based studies have suggested that the diabetes drug metformin may combine with the anaplastic lymphoma kinase receptor (ALK) inhibitor crizotinib to increase ALK positive lung …
C Hou, Y Hu, T Zhang - Anti-Cancer Drugs, 2024 - journals.lww.com
The objective was to investigate curcumin's (Cur) function and associated molecular mechanisms in regulating tumor immunity in colon cancer. Primary cancer-associated …